Background. Four spotted fever group rickettsiae (SFGR) are known to infect humans in the United States. A member of the SFGR designated 364D and detected in Dermacentor occidentalis ticks has not previously been identified as a human pathogen.
6]. The first human case of RMSF in California was identified in 1903, with 238 cases reported between 1903 and 1973 (California Department of Public Health, unpublished data). However, although these cases were diagnosed principally on clinically compatible symptoms (ie, fever, headache, and rash), since 1981, only 1-2 cases have been reported each year that meet both the clinical and laboratory criteria (ie, a у4-fold change in specific antibody titer to R. rickettsii) for a confirmed case of RMSF [5, 7, 8] , as specified in the national surveillance case definition (http://www.cdc .gov/ncphi/disss/nndss/casedef/case_definitions.htm).
Each of the classically recognized vectors of RMSFnamely Dermacentor variabilis and Dermacentor andersoni-and a newly recognized US vector (Rhipicephalus sanguineus [2] ) occur in California. Historically, a large proportion of cases of RMSF in California were reported from the northeastern Modoc Plateau area where D. andersoni occurs. However, since 1950, an increasing proportion of cases have been reported outside the Modoc Plateau in areas of the state where D. andersoni is absent, suggesting that other ticks might be responsible for occasional transmission of the disease [9] . Both D. variabilis and Dermacentor occidentalis (the Pacific Coast tick) ( Figure 1 ) are abundant in the coastal ranges from spring to early summer, coincident with many recent California RMSF cases [9, 10] . However, in California to date, R. rickettsii has not been detected in D. variabilis but only in R. sanguineus and D. occidentalis [11] [12] [13] . In addition to uncertainty about which tick species are the principal vectors for RMSF in California, because R. rickettsii has never to our knowledge been isolated from an autochthonously exposed California patient, other species of SFGR may cause illnesses that resemble and are misdiagnosed as RMSF [14] [15] [16] .
Several investigators have speculated that 364D, a SFGR closely related to R. rickettsii and commonly found in D. occidentalis, might infect humans in California [11, 13, [16] [17] [18] [19] . Dermacentor occidentalis rarely harbors R. rickettsii in California; a recent study detected R. rickettsii in only 0.3% of D. occidentalis in southern California [13] . In contrast, 364D has been detected in up to 11% of D. occidentalis from 8 California counties where D. andersoni is absent [13, 19] . Because the clinical features and commercial serodiagnostic assays for RMSF lack specificity within the SFGR, an unknown proportion of these cases may represent infection with other species of SFGR. Herein, we report 1 laboratory-confirmed case and 3 similar possible cases of infection with 364D from a rural region of northern California.
CASE REPORT
An 80-year-old male resident (patient 1) of Lake County, California, presented to the emergency department of a local hospital in July 2008 with progressive swelling and erythema of his left forearm. Although not disclosed at the time, the patient later recalled having a small black spot at the site 3 days earlier that he initially attributed to a possible insect bite; whether this represented a nascent eschar or the arthropod itself is unknown. He had not travelled outside Lake County during the 10 weeks preceding his illness. The patient had no contact with wild or domestic animals.
Physical examination revealed a -cm vesicular patch 2 ϫ 3 with surrounding erythema on the proximal forearm. The patient reported left axillary pain and tenderness, but was afebrile and without other symptoms. Trimethoprim-sulfamethoxazole (160/800 mg every 12 h) was prescribed for suspected bacterial infection and the patient was released.
The patient presented to his internist three days later at which time the forearm lesion consisted of a 0.4-cm ulcer with raised erythematous margins, surrounded by a 2.0-2.5-cm zone of induration, maceration, and vesiculation ( Figure 2A ). Generalized erythema extended approximately to the wrist and elbow. Because a rickettsial etiology was considered at this time, antimicrobial therapy was changed to doxycycline (100 mg every 12 h), and an acute-phase serum sample was collected for serological testing. The specimen was negative (titer, !1:64) for immunoglobulin (Ig) G antibodies to R. rickettsii by immunofluorescence assay (IFA) conducted at a commercial reference laboratory.
Seven days later, the lesion had developed into a 0.8-cm ulcer beneath an unroofed, irregular 1.5-cm eschar, surrounded by a few smaller satellite ulcers. The ulcer resembled cutaneous lesions observed in 3 other patients (patients 2-4) from the same community ( Figure 1B and Table 1 clinical presentations, positive responses to treatment with doxycycline, and positive results reported for R. rickettsii serologic tests conducted at a commercial laboratory. A 0.3-cm punch biopsy specimen of the skin and eschar was obtained from patient 1, fixed in 10% buffered formalin, and sent to the Centers for Disease Control and Prevention (Atlanta, GA) for laboratory evaluation of eschar-associated infectious agents, including Bacillus anthracis and SFGR. One week after completing a 14-day course of doxycycline, the skin lesion had completely resolved. The patient remained afebrile and reported no systemic symptoms throughout the course of his illness. A convalescent-phase serum sample collected 27 days after onset and evaluated at the same commercial laboratory was positive (titer, 1:512) for IgG antibodies to R. rickettsii. 
METHODS

Serological testing.
Antibodies to SFGR antigens were measured by IFA and by western blotting (WB). R. rickettsii strain Sheila Smith, R. rhipicephali strain 3-7-6&, and 364D were cultivated in Vero E6 cells and prepared as antigens for IFA and WB as previously described [3, 20] . Serum samples were screened by IFA at consecutive 2-fold serum dilutions starting at 1:32 to end-point using heavy chain specific conjugates. IgG and IgM titers у1:64 were considered to be positive; seroconversion was defined as a у4-fold change in titer between 2 serum specimens collected at least 2 weeks apart. For WB, purified antigens were separated through 10% SDS polyacrylamide gel and blots were prepared using 0.45-mm nitrocellulose membranes as described [20] . All patient serum samples were tested by immunoblot at a final dilution of 1:100. Histopathologic and immunohistochemical tests. The fixed tissue sample was processed for paraffin embedding. Sections (3 mm) were stained with hematoxylin and eosin, Grocott's methenamine silver, Warthin-Starry, and Gram stains and by an immunoalkaline phosphatase technique [3] using a polyclonal anti-R. rickettsii antibody diluted at 1:500, 2 monoclonal anti-B. anthracis antibodies (1:200 and 1:1000), and a polyclonal anti-Sporothrix schenckii antibody (1:500).
Molecular analyses. DNA was extracted from a 10-mm section of the formalin-fixed, paraffin-embedded skin biopsy specimen. Polymerase chain reaction (PCR) detection and molecular identification of rickettsiae were performed by amplification of the fragments of the 17 kDa protein antigen and outer membrane protein (OmpA) genes using nested or seminested assays [4, 15] . RR0155-rpmB and RR1240-tlc5 intergenic regions were amplified with nested primers [21] . Specific information on the molecular assays and results are provided in Table 2 . Collection and analysis of ticks. Ticks were collected near the residences of patients 1 and 2 in August 2008 using flannel flags and carbon dioxide traps. Ticks were identified to species using standard taxonomic keys and maintained at 4ЊC until processed for DNA for SYBR Green PCR testing and PCR and sequencing of ompA amplicons (Table 2) [13] .
RESULTS
Serological tests.
The convalescent-phase specimen from patient 1 exhibited high IgG titers to R. rickettsii, R. rhipicephali, and 364D antigens, ranging from 1:1024 to 1:2048. Similar reactivity patterns were detected for serum samples collected and tested from patients 2-4 (Tables 1 and 3 ). Earlier serum specimens were available for only 2 of the presumptive cases; seroconversion to all 3 antigens was demonstrated for patient 3. Patient 4 exhibited seroconversion when tested using R. rhipicephali antigen, but only 2-fold titer increases were seen for both R. rickettsii and 364D. Antibodies to SFGR were also characterized by WB ( Figure  3) . A convalescent-phase serum sample from patient 1 exhibited strong reactivity with the high molecular weight protein antigens, OmpA and OmpB. The reactivity was strongest with antigens from R. rhipicephali, followed by R. rickettsii and 364D. Similar patterns were observed for serum samples from patients 2-4. Serum samples from patients 1 and 3 exhibited reactivity to rickettsial lipopolysaccharide; the serum sample from patient 2 also reacted to the GroEL 60 kDa heat-shock protein antigen, although both intensities were much weaker compared to reactivity with the high-molecular weight protein antigens.
Histopathologic and immunohistochemical tests. The biopsy specimen from patient 1 showed prominent necrosis of the epidermis and superficial dermis, with fragmented and intact inflammatory cells comprising lymphocytes, macrophages, and neutrophils admixed sparsely with the necrotic tissue (Figure 2C) . The most intense inflammatory infiltrates, consisting of lymphocytes and macrophages, were distributed diffusely throughout the full thickness of the dermis and extended into the subcutaneous fat ( Figure 2D ). Unusual components of this lesion included numerous eosinophils in some areas of dermatitis and panniculitis ( Figure 2D ) and the absence of conspicuous vasculitis. No bacteria or fungi were detected by using Figure 2E and 2F) .
Molecular analyses. A 208-bp fragment of the 17 kDa Rickettsia antigen gene was amplified from DNA extracted from a formalin-fixed skin sample. Two ompA fragments (70-602 nucleotides and 101-678 nucleotides) were also amplified; their sequences were identical to that of the homologous fragment of 364D (GenBank accession no. EU109181), which differs from R. rickettsii in 3 nucleotide positions. The 361-bp and 292-bp fragments of the RR0155-rpmB and RR1240-tlc5 intergenic regions were identical to the homologous fragments from the type strain of 364D, and differed by 13 and 7 nucleotides, respectively, from the homologous regions of R. rickettsii Sheila Smith (Table 2 ) [21] .
Analysis of ticks. Fourteen D. variabilis, 4 Haemaphysalis leporispalustris, 19 D. occidentalis, and 149
Ornithodoros coriaceus were tested. Three adult D. occidentalis were positive for SFGR: 364D (1 male), R. rhipicephali (1 male), and an unidentified Rickettsia (1 female). Identification to species of Rickettsia could not be completed for the third tick due to the low amount of rickettsial DNA detected. All positive ticks were collected within 1 km of patient 1's residence; the single adult D. occidentalis collected on his property was negative. Rickettsial DNA was not detected in any other tick species.
DISCUSSION
The patient described here presented with a cutaneous lesion that progressed to an ulcer as the chief clinical abnormality. The differential diagnosis for isolated ulcers and eschars encompasses numerous noninfectious and infectious etiologies, including anthrax, tularemia, lymphogranuloma venereum, orf, and cat scratch disease. Although the classic dermatologic manifestation of infection with R. rickettsii is a diffuse maculopapular or petechial rash that involves the palms and soles, atypical cutaneous manifestations including "spotless" fever and eschars have also been occasionally reported in patients with serum antibodies to R. rickettsii [22] [23] [24] . Other SFGR, including R. conorii and R. aeschlimannii, have been reported to cause illnesses in which an eschar was the sole clinical manifestation [25, 26] . More than 10% of patients seen at a university medical center in an endemic area who met national surveillance criteria for probable or confirmed RMSF had atypical or no cutaneous manifestations [27] . Similarly, California cases reported as RMSF frequently lack the classic triad of fever, macular rash, and history of tick bite. Diagnoses in most of these cases are based principally on commercial laboratory reports of serum antibodies to R. rickettsii. However, as standard serologic assays do not differentiate infections caused by SFGR, an unknown proportion of such cases in California and elsewhere may represent infection with other SFGR. In the present study, all 4 patients had elevated convalescent-phase serum antibody titers to R. rickettsii, R. rhipicephali, and 364D; of the 2 patients for whom paired serum samples were available, patient 3 seroconverted to all 3 agents and patient 4 seroconverted to R. rhipicephali and had 2-fold rises in titer to R. rickettsii and 364D. None of the 4 patients had IFA or WB results that permitted specific serological identification of the etiology of the spotted fever group rickettsiosis they experienced. These results illustrate the profound cross-reactivity among SFGR antigens that diminishes the specificity of conventional serologic assays and underscore the need for culture or molecular-based techniques to accurately identify the etiologic agent responsible for a SFG rickettsiosis [1, 3, 4, 6, 20, 28] . This level of diagnostic specificity will help to define the clinical spectrum of infection with other SFGR, including 364D, and may explain "atypical RMSF" in areas where R. rickettsii is not prevalent or not the sole SFGR present. A biopsy of the eschar was instrumental for correctly identifying the pathogen in the case described here and should be considered for patients who present with similar illnesses [3, 4, 6, [22] [23] [24] 27] . Prolonged persistence of the SFGR in areas of poorly perfused tissue at the margin between viable and necrotic tissue in gangrenous extremities and eschars has been previously described [29, 30] , and a similar process was perhaps observed in patient 1 who received extended antibiotic treatment prior to the biopsy procedure.
Three other patients (patients 2-4) with cutaneous lesions were investigated retrospectively. Each reported headache 2-14 days before noticing the skin lesion, and 2 reported fever. Two patients recovered after a 2-week course of doxycycline. The remaining patient initially started receiving doxycycline, but the regimen was changed to ciprofloxacin (500 mg twice per day for 2 weeks) for suspected cutaneous anthrax, then subsequently completed 2 weeks of doxycycline after anthrax was excluded and an erythematous macule persisted. Each had elevated serum IgG to SFGR, including R. rickettsii, R. rhipicephali, and 364D, but the lack of molecular analysis of the skin lesions precluded a definitive identification of the true etiologic agent. Indeed, prior infection with any SFGR may produce cross-reactive serum antibodies that not only confound interpretation of results of serologic assays but may provide some level of protective immunity that reduces the severity of clinical disease following infection with other SFGR, as has been previously reported in dogs experimentally infected with R. rhipicephali [31] . Approximately 15 of the 20 SFGR species known worldwide are recognized as pathogenic to humans. In 1966, a SFGR named 364D was first identified in D. occidentalis ticks in Ventura County, California [11, [17] [18] [19] . Isolates of 364D evaluated to date are serologically and biologically homogeneous, cause mild illness in guinea pigs and voles, and are cytopathic for Vero cells and kill chicken embryos [19] . Recent molecular testing has identified unique differences between 364D and isolates of R. rickettsii in 18 of 28 intergenic regions [21] and comparisons of the complete genome sequences of 364D with those of R. rickettsii Sheila Smith and Iowa further support species status for 364D (authors' unpublished data).
Among California ticks, 364D has been identified only in D. occidentalis, a species that occasionally bites humans [32] and is common throughout much of California [10] . In northern California, adult D. occidentalis are most active March through May [33] , whereas nymphal D. occidentalis are more commonly encountered June through August [34] . One study [13] estimated that 7.8% of D. occidentalis in southern California were infected with 364D, compared with !1% with R. rickettsii. 364D and R. rhipicephali were detected in D. occidentalis ticks in Lake County first in 1980 [19] and again in the present study. Pending experimental transmission studies to verify its vector competence, the available evidence indicates that D. occidentalis is the likely vector for 364D in California.
The 4 patients described here were from a single practice area and had similar, mild illnesses; further investigation is required to elucidate the clinical spectrum of infection with this newly recognized pathogen, the range of its distribution, and its contribution to human morbidity. Because 364D shares many antigens with other SFGR that preclude serological differentiation, molecular identification or isolation of rickettsiae from patient tissues is required for a definitive etiologic diagnosis of this and any other spotted fever group rickettsiosis.
